Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia
Open Access
- 21 April 2021
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (5) , 327
Abstract
We measured P300, an event-related potential, in subjects with at-risk mental states (ARMS) and aimed to determine whether P300 parameter can predict progression to overt schizophrenia. Thirty-three subjects with ARMS, 39 with schizophrenia, and 28 healthy controls participated in the study. All subjects were antipsychotic-free. Subjects with ARMS were followed-up for more than two years. Cognitive function was measured by the Brief assessment of Cognition in Schizophrenia (BACS) and Schizophrenia Cognition Rating Scale (SCoRS), while the modified Global Assessment of Functioning (mGAF) was used to assess global function. Patients with schizophrenia showed smaller P300 amplitudes and prolonged latency at Pz compared to those of healthy controls and subjects with ARMS. During the follow-up period, eight out of 33 subjects with ARMS developed overt psychosis (ARMS-P) while 25 did not (ARMS-NP). P300 latency of ARMS-P was significantly longer than that of ARMS-NP. At baseline, ARMS-P elicited worse cognitive functions, as measured by the BACS and SCoRS compared to ARMS-NP. We also detected a significant relationship between P300 amplitudes and mGAF scores in ARMS subjects. Our results suggest the usefulness of prolonged P300 latency and cognitive impairment as a predictive marker of later development of schizophrenia in vulnerable individuals.Keywords
Funding Information
- Japan Society for the Promotion of Science (18K07550, 16K10205, JP20H03598, 26461739)
- Japan Agency for Medical Research and Development (JP19dk0307029)
This publication has 72 references indexed in Scilit:
- Mismatch Negativity and Cognitive Performance for the Prediction of Psychosis in Subjects with At-Risk Mental StatePLOS ONE, 2013
- Differentiation of Schizophrenia Patients from Healthy Subjects by Mismatch Negativity and Neuropsychological TestsPLOS ONE, 2012
- White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI–EEG studyJournal of Psychiatry and Neuroscience, 2011
- Classification of First-Episode Schizophrenia Patients and Healthy Subjects by Automated MRI Measures of Regional Brain Volume and Cortical ThicknessPLOS ONE, 2011
- Clinical practice and research activities for early psychiatric intervention at Japanese leading centresEarly Intervention in Psychiatry, 2009
- Abnormal P300 in people with high risk of developing psychosisNeuroImage, 2008
- Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: A LORETA analysis of P300Schizophrenia Research, 2008
- Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese versionPsychiatry and Clinical Neurosciences, 2007
- Cognitive therapy for the prevention of psychosis in people at ultra-high riskThe British Journal of Psychiatry, 2004
- Neural Origins of the P300Critical Reviews™ in Neurobiology, 2000